| scholarly article | Q13442814 |
| P50 | author | Joseph Vita | Q42637117 |
| P2093 | author name string | R W Alexander | |
| W S Colucci | |||
| J B Gordon | |||
| A P Selwyn | |||
| M G Sutton | |||
| C B Treasure | |||
| G H Mudge | |||
| D A Cox | |||
| R D Fish | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 772-779 | |
| P577 | publication date | 1990-03-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy | |
| P478 | volume | 81 |
| Q40548139 | "Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy |
| Q52325352 | A model of electrical activity and cytosolic calcium dynamics in vascular endothelial cells in response to fluid shear stress. |
| Q44567991 | Abnormal coronary microvascular endothelial function in humans with asymptomatic left ventricular dysfunction |
| Q51334798 | Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction. |
| Q52017734 | Abnormal left ventricular ejection fraction response to mental stress and exercise in cardiomyopathy. |
| Q54109046 | Activation of Large Conductance, Calcium-Activated K Channels by Nitric Oxide Mediates Apelin-Induced Relaxation of Coronary Arteries. |
| Q42541066 | Acute hemodynamic effects of endogenous adenosine in patients with chronic heart failure |
| Q44360973 | Adeno-associated virus mediated gene delivery into coronary microvessels of chronically instrumented dogs |
| Q36996413 | Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure |
| Q71879928 | Aging-associated endothelial dysfunction in humans is reversed by L-arginine |
| Q34041396 | Aldosterone, a new appreciation of its role in heart failure |
| Q43160404 | Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction |
| Q74454584 | Altered vascular function in early stages of heart failure in hamsters |
| Q73031662 | Altered vasodilator response of coronary microvasculature in pacing-induced congestive heart failure |
| Q78238101 | Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts |
| Q38044305 | Anticoagulation in heart failure: current status and future direction |
| Q30619167 | Antifailure therapy including spironolactone improves left ventricular energy supply-demand relations in nonischemic dilated cardiomyopathy |
| Q38164671 | Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal |
| Q37980252 | Are endothelial progenitor cells a prognostic factor in patients with heart failure? |
| Q33588636 | Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy |
| Q90269708 | Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial |
| Q38466514 | Basal and hyperaemic myocardial blood flow in regionally denervated canine hearts: an in vivo study with positron emission tomography |
| Q51542476 | Beneficial effects of renal denervation on cardiac angiogenesis in rats with prolonged pressure overload. |
| Q35035923 | Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity |
| Q92813722 | Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding |
| Q73635126 | Chronic exercise training preserves prostaglandin-induced dilation of epicardial coronary artery during development of heart failure in awake dogs |
| Q44848201 | Comparison of resistance and conduit vessel nitric oxide-mediated vascular function in vivo: effects of exercise training. |
| Q52911636 | Coronary arterial dimension-to-left ventricular mass ratio in idiopathic dilated cardiomyopathy. |
| Q33811458 | Coronary artery blood flow: physiologic and pathophysiologic regulation |
| Q43930831 | Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy |
| Q32052640 | Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy |
| Q43914989 | Coronary flow velocity reserve in hypertensive patients with left ventricular systolic dysfunction |
| Q35514359 | Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT |
| Q74391357 | Coronary vascular responsiveness to adenosine is impaired additively by blockade of nitric oxide synthesis and a sulfonylurea |
| Q38009708 | Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure |
| Q61650824 | Detecting the impact of emerging cardiovascular risk factors: The role of positron emission tomography |
| Q38061830 | Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion |
| Q33302962 | Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes |
| Q77989787 | Differential coronary microvascular function in patients with left ventricular dysfunction of unknown cause--implication for possible mechanism of myocardial ischemia in early stage of cardiomyopathy |
| Q45984844 | Diffuse, marked, reversible impairment in coronary microcirculation in stress cardiomyopathy: a Doppler transthoracic echo study. |
| Q36267218 | Echocardiographic and hemodynamic determinants of right coronary artery flow reserve and phasic flow pattern in advanced non-ischemic cardiomyopathy |
| Q55034263 | Effect of aerobic and resistance exercise training on vascular function in heart failure. |
| Q35890896 | Effect of exercise training on endothelium-derived nitric oxide function in humans. |
| Q30493299 | Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats |
| Q36836456 | Effects of Epicardial and Endocardial Cardiac Resynchronization Therapy on Coronary Flow: Insights From Wave Intensity Analysis. |
| Q84965633 | Effects of continuous flow left ventricular assist device support on microvascular endothelial function |
| Q46863577 | Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure |
| Q36014122 | Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy |
| Q77353827 | Effects of short-term forearm exercise training on resistance vessel endothelial function in normal subjects and patients with heart failure |
| Q40405195 | Endogenous nitric oxide in cardiovascular disease and transplantation |
| Q37222753 | Endothelial and non-endothelial coronary blood flow reserve and left ventricular dysfunction in systemic hypertension. |
| Q44314878 | Endothelial dysfunction and reduced myocardial perfusion reserve in heart failure secondary to coronary artery disease |
| Q37394140 | Endothelial dysfunction and vascular disease |
| Q38680112 | Endothelial dysfunction and vascular disease - a 30th anniversary update |
| Q38247988 | Endothelial dysfunction as a nexus for endothelial cell-cardiomyocyte miscommunication. |
| Q74308739 | Endothelial dysfunction in chronic heart failure: clinical and therapeutic implications |
| Q73622513 | Endothelial dysfunction in patients with heart failure: relationship to disease severity |
| Q37271463 | Endothelial dysfunction over the course of coronary artery disease |
| Q46374461 | Endothelial function is preserved in Chagas' heart disease patients without heart failure. |
| Q44960064 | Endothelial-mediated coronary flow reserve and its relation to mitral annular tissue Doppler velocities in offspring of hypertensive parents |
| Q34170380 | Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension |
| Q40678289 | Enhanced nitric oxide bioavailability in coronary arteries prevents the onset of heart failure in rats with myocardial infarction |
| Q48887068 | Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia. |
| Q61716910 | Etiology and response to drug treatment in heart failure |
| Q44650124 | Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy |
| Q36813507 | Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure |
| Q35576240 | Exercise and the nitric oxide vasodilator system |
| Q37980343 | Exercise as a nonpharmacologic intervention in patients with heart failure |
| Q40457694 | Exercise intolerance in patients with chronic heart failure. |
| Q49917782 | Exercise training induces eNOS coupling and restores relaxation in coronary arteries of heart failure rats. |
| Q44559057 | Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations |
| Q44158710 | Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure |
| Q77398515 | Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart |
| Q46769548 | Extravascular pressure modulates responses of isolated rat coronary arteries to vasodilator, but not vasoconstrictor, stimuli. |
| Q46598571 | Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure |
| Q73386864 | Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation |
| Q74172116 | Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension |
| Q55252925 | Immune-regulating effects of exercise on cigarette smoke-induced inflammation. |
| Q90028050 | Immunomodulatory Action of Substituted 1,3,4-Thiadiazines on the Course of Myocardial Infarction |
| Q63479554 | Impaired endothelium-dependent relaxation in large, but not small arteries in rats after coronary ligation |
| Q73916551 | Impairment in forearm endothelium-dependent vasodilation after heart transplantation |
| Q37622037 | Impairment of subendocardial perfusion reserve and oxidative metabolism in nonischemic dilated cardiomyopathy |
| Q41673266 | Improvement of cardiac performance by intravenous infusion of l-arginine in patients with moderate congestive heart failure |
| Q31722034 | Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure |
| Q43800037 | Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure |
| Q34119551 | Increased production of nitric oxide in coronary arteries during congestive heart failure |
| Q36835377 | Inhibitors of the renin-angiotensin system in established cardiac failure |
| Q54480868 | Is the mechanism of idiopathic dilated cardiomyopathy coronary related after all? |
| Q37352122 | Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy |
| Q73476752 | Isolated defect of adenosine-mediated coronary vasodilation: functional evidence for a new microangiopathic entity |
| Q84357355 | Lagged segmented Poincaré plot analysis for risk stratification in patients with dilated cardiomyopathy |
| Q50100084 | Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy. |
| Q73226891 | Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human hearts |
| Q40913112 | Local contractile and growth modulators in the myocardium |
| Q51564787 | Loss of nitric oxide production in the coronary circulation after the development of dilated cardiomyopathy: a specific defect in the neural regulation of coronary blood flow. |
| Q74012808 | Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia |
| Q75339558 | Microvascular abnormalities in chronic heart failure: a cross-sectional analysis |
| Q37310855 | Microvascular angina. Cardiovascular investigations regarding pathophysiology and management |
| Q44735500 | Mitochondrial respiratory abnormalities in patients with end-stage congenital heart disease |
| Q52687612 | Multiple Avenues of Modulating the Nitric Oxide Pathway in Heart Failure Clinical Trials. |
| Q46161569 | Myocardial blood flow in patients with dilated cardiomyopathy: quantitative assessment with velocity-encoded cine magnetic resonance imaging of the coronary sinus |
| Q48444942 | Myocardial blood volume reserve by intravenous contrast echocardiography predicts improvement in left ventricular function in patients with nonischemic dilated cardiomyopathy. |
| Q34658325 | Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application |
| Q33838831 | Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy |
| Q73787547 | Myocardial reactive hyperemia in experimental chronic heart failure: evidence for the role of K+ adenosine triphosphate-dependent channels and cyclooxygenase activity |
| Q77976715 | Myocyte loss in chronic heart failure |
| Q40988769 | Neural and endothelial control of the peripheral circulation--implications for anesthesia: Part II, Endothelium-mediated effects in the normal and diseased circulation |
| Q34534382 | Nicorandil prevents Gαq-induced progressive heart failure and ventricular arrhythmias in transgenic mice |
| Q33641341 | Nitric Oxide and Related Aspects Underlying Angina |
| Q73807241 | Nitric oxide in heart failure |
| Q43988600 | Nitric oxide production is maintained in exercising swine with chronic left ventricular dysfunction |
| Q78659297 | Nitric oxide-dependent vasodilation in human subjects |
| Q38221514 | Noninvasive assessment of endothelial function: the classic methods and the new peripheral arterial tonometry |
| Q37086309 | Overview of emerging pharmacologic agents for acute heart failure syndromes |
| Q46542084 | PGE1 analog alprostadil induces VEGF and eNOS expression in endothelial cells. |
| Q36342542 | Pathways of myocyte death: implications for development of clinical laboratory biomarkers |
| Q34622165 | Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure |
| Q57165922 | Physiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease |
| Q41870192 | Poly(ADP-ribose) polymerase inhibition improves endothelin-1-induced endothelial dysfunction in rat thoracic aorta |
| Q37121936 | Preservation of NO production by statins in the treatment of heart failure |
| Q79367030 | Quantitative analysis of peroxisome proliferator-activated receptor gamma (PPARgamma) expression in arteries and hearts of patients with ischaemic or dilated cardiomyopathy |
| Q92106562 | Redox Regulation of the Microcirculation |
| Q38383375 | Redox-sensitive mechanisms underlying vascular dysfunction in heart failure |
| Q42002347 | Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy |
| Q35588612 | Reduced skeletal muscle oxidative capacity and impaired training adaptations in heart failure |
| Q28368321 | Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy |
| Q43796177 | Reversibility of coronary endothelial vasomotor dysfunction in idiopathic dilated cardiomyopathy: acute effects of vitamin C. |
| Q35088049 | Role of heme in cardiovascular physiology and disease |
| Q34623680 | Role of nitric oxide in the regulation of substrate metabolism in heart failure |
| Q34025110 | SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells |
| Q46711272 | Selective right, but not left, coronary endothelial dysfunction precedes development of pulmonary hypertension and right heart hypertrophy in rats |
| Q37098893 | Simvastatin preserves cardiac function in genetically determined cardiomyopathy |
| Q38012596 | Soluble guanylate cyclase: a potential therapeutic target for heart failure |
| Q37691303 | St Cyres lecture. Endothelium in control |
| Q35936804 | Statin therapy for cardiac hypertrophy and heart failure |
| Q36110624 | Statins and the myocardium |
| Q73627050 | Superiority of endothelin-1 over norepinephrine in exercise-induced alterations of the conduit artery tone of the non-exercised arm in patients with chronic heart failure |
| Q28375411 | Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts |
| Q46702778 | T3 and T4 decrease ROS levels and increase endothelial nitric oxide synthase expression in the myocardium of infarcted rats |
| Q33863759 | Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training. |
| Q45004497 | Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia |
| Q38330360 | The Endothelium as a Target for the Treatment of Heart Failure |
| Q36547176 | The Human Microcirculation: Regulation of Flow and Beyond |
| Q53619016 | The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats. |
| Q40386404 | The arginine-nitric oxide pathway: a target for new drugs. |
| Q45957622 | The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury. |
| Q34532281 | The nitric oxide-endothelin-1 connection |
| Q74660329 | The pathophysiology of advanced heart failure |
| Q43960927 | The presence of African American race predicts improvement in coronary endothelial function after supplementary L-arginine |
| Q46933177 | The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy |
| Q40457699 | The role of endothelium-derived vasoactive substances in the pathophysiology of exercise intolerance in patients with congestive heart failure |
| Q71337411 | The role of nitric oxide in heart failure. Potential for pharmacological intervention |
| Q34222988 | The role of nitric oxide in the failing heart |
| Q51068350 | The utility of novel non-invasive technologies for remote hemodynamic monitoring in chronic heart failure. |
| Q77700106 | Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine |
| Q37939117 | Thrombophilia, left ventricular dysfunction and intracardiac thrombi in children |
| Q46087090 | Variable response of conductance and resistance coronary arteries to endothelial stimulation in patients with heart failure due to nonischemic dilated cardiomyopathy |
| Q58314430 | Variable response of the peripheral circulation to acetylcholine in patients with coronary artery disease |
Search more.